Sun Pharma gets nod to make generic Wegovy

Sun Pharmaceutical Industries has received approval to manufacture a generic version of the weight-loss drug Wegovy. The company aims to launch its product by March, offering it in five dosage strengths that mirror the original formulation by Novo Nordisk. This move marks a significant step for Sun Pharma as it enters the lucrative obesity treatment market, which has seen increased demand in recent years. The generic version is expected to provide a more affordable alternative to Wegovy, potentially expanding access to effective weight management solutions. By aligning its dosage options with the established brand, Sun Pharma ensures that healthcare providers can seamlessly transition patients to the new offering without altering treatment plans. This strategic alignment may enhance the drug's acceptance among both physicians and patients. Sun Pharma's entry into the market comes at a time when obesity is a growing global health concern, with millions seeking effective treatments. As the company prepares for the launch, it will focus on ramping up production and distribution to meet anticipated demand. The introduction of a generic version is likely to intensify competition in the sector, potentially driving innovation and further developments in obesity management therapies.

— Authored by Next24 Live